Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Vaccine Adjuvants Market?

The vaccine adjuvants industry has seen dynamic growth in the past years. The market is expected to rise from $1.89 billion in 2024 to $2.01 billion in 2025, with an annual compound growth rate (CAGR) of 6.6%. This notable growth during the previous period is largely due to the rise in vaccine development, the prevalence of infectious diseases, the initiation of government programs for immunization, investments in research and development, and the globalization of vaccine distribution.

The market size of vaccine adjuvants is projected to experience robust growth in the upcoming years, escalating to $2.83 billion by 2029 with a compound annual growth rate (CAGR) of 8.9%. Factors contributing to this growth in the prediction period include readiness for pandemics, an increasing vaccine portfolio, international immunization objectives, collaborations, and strategic partnerships, and an emphasis on therapeutic vaccines. Trends expected during this prediction period are developments in adjuvant technologies, increased focus on improving immunogenicity, the use of combined adjuvants for heightened effectiveness, the need for safer and better-tolerated adjuvants, and the emergence of personalized vaccines and adjuvants.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10121&type=smp

Which Factor Is Shaping The Future Of The Vaccine Adjuvants Market?

The escalating frequency of infectious diseases has the potential to boost the growth of the vaccine adjuvants market in the future. These diseases, induced by viruses, bacteria, fungi, or parasites, are treated with immunizations for conditions like hepatitis B (HBV), hepatitis C (HCV), HIV, malaria, syphilis, and brucellosis. To illustrate, the 2022 report from the World Health Organization (WHO) revealed that there were around 10.6 million global tuberculosis cases in 2021, resulting in 1.6 million deaths. Moreover, in the same year, 1.5 million people contracted HIV, and 650,000 people succumbed to the disease. Therefore, the increasing occurrence of infectious diseases will enhance the growth of the vaccine adjuvants market.

The vaccine adjuvants market covered in this report is segmented –

1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types

2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants

3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal

4) By Disease: Cancer, Infectious Diseases, Other Diseases

Subsegments:

1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions

2) By Pathogen Components: Bacterial Components, Viral Components

3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles

4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems

5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants

Which Emerging Trends And Strategic Shifts Are Shaping The Vaccine Adjuvants Market?

One of the main trends seen in the vaccine adjuvants market revolves around product innovation. Players in this market are strategically adopting innovative solutions to solidify their standing. Evonik Industries, a Germany-based company specializing in chemical manufacturing, for instance, rolled out PhytoSquene in December 2022. This plant-based product derived from amaranth oil is a sustainable substitute for the conventional shark-derived squalene, and is primed for usage in vaccine adjuvants as well as other pharmaceutical applications in order to augment vaccine effectiveness by catalyzing immune responses. This move underscores the growing focus on sustainability within the pharmaceutical industry.

Which Companies Hold The Largest Market Share In The Vaccine Adjuvants Sector?

Major companies operating in the vaccine adjuvants market include GlaxoSmithKline Plc., Novavax Inc., SPI Pharma Inc., Agenus Inc., CSL Limited, InvivoGen Limited., Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd, SBI Biotech Co. Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc., Aphios Corporation

https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

How Does Regional Performance Compare Across The Vaccine Adjuvants Industry?

North America was the largest region in the vaccine adjuvants market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10121&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model